Navigation Links
Nutralife Hails New Study’s Findings on SAM-e, Giving Hope to Millions Seeking Joint Relief
Date:4/4/2013

Lakewood,NJ (PRWEB) April 04, 2013

The popular supplement S-Adenosyl Methionine, commonly known as SAMe received the highest rating for all supplements in a recent report evaluating the efficacy of many supplements taken for osteoarthritis. Once again this study reiterates the value of SAMe and offers significant hope for the 27 million plus Americans who suffer from osteoarthritis on a daily basis.

In the report released by Arthritis Research UK, a major medical research organization in England, researchers evaluated 31 complementary medicines taken either by mouth or applied to the skin that were found to have quality studies available. Each was scored for effectiveness based on users’ improvements in pain, disability or quality of life on a scale of 1 to 5, with “1” suggesting the lowest degree of efficacy and “5” suggesting the highest. SAMe received a 4, the highest rating of all the supplements for arthritis relief.

“The results of this study are not surprising to us,” stated Abigail Glass, President and Founder of Nutralife Health Products (NHP), a New Jersey based company that has been distributing SAMe supplements for over a decade. “Our customers have constantly been reporting back to us that SAMe has helped rejuvenate their joints, like no other supplement.” According to the Textbook of Natural Medicine (Michael T. Murray, 2006), a total of 21,524 patients with osteoarthritis have utilized SAMe in detailed clinical trials. In double-blind trials, SAMe has demonstrated similar reductions in pain scores and clinical symptoms to those produced by nonsteroidal anti-inflammatory drugs (NSAIDs) and was found to be generally much better tolerated.

“We are pleased that the benefits and scientific evidence of the efficacy of SAMe has been reiterated,” says Ephraim Glass, VP of Marketing at Nutralife Health Products. “Because of the staggering amount of consumers suffering from osteoarthritis, it is important that they are able to make informed decisions about the supplements they purchase.” There are 27 million people in the United States who suffer from osteoarthritis, and the number is on the rise according to a recent CDC report. According to a US government report released in 2013 by the AHRQ (Agency for Healthcare Research and Quality), a division of the National Institute of Health; Osteoarthritis was the most common diagnosis among adults ages 45-84 in 2010.

“We know that SAMe is truly a unique product,” says Sarah Levi, VP of Research and Development at Nutralife Health Products. “SAMe has been around for decades, has been the subject of numerous clinical trials and reviews, and is time and again proven effective.”

Nutralife Health Products introduced SAMe into the United States in the 1990s, and it remains a leading brand in SAMe distribution. NHP’s SAMe is available in 200mg and 400mg doses and contain the trademarked (S)SAMe, Nutralife’s proprietary SAMe raw material.

Nutralife has always been at the forefront of SAMe research. “We hope that by promoting consumer awareness, many more people will realize the benefits of SAMe,” stated Abigail Glass.

To see the full report by Arthritis Research UK, see the following link: http://www.arthritisresearchuk.org/arthritis-information/complementary-and-alternative-medicines/complementary-and-alternative-medicines.aspx

About NutraLife™ Health Products:

NutraLife™ Health Products (NHP), a women-owned business, was founded in 1996 by two women with one goal: to provide health-conscious individuals with natural, safe, and clinically-proven dietary supplements. NHP features a complete line of vitamins and supplements under the NutraLife™ brand. NutraLife™ SAMe products are among the leading selling SAMe SKU’s in the nutritional supplement category according to IRI, and can be found at prominent retailers such as Walgreens and CVS.

To find out more about Nutralife SAMe, please contact Nutralife Health Products.

Nutralife Health Products
1-877-688-7254
http://www.nutralifesame.com
http://www.joint-rite.com

Read the full story at http://www.prweb.com/releases/2013/4/prweb10555295.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Nutralife Health Products Inc. Announces Launch of New Website for its Revolutionary Joint Supplement, JointRite
2. New England Journal of Medicine hails new skin cancer drug as greatest advance yet
3. New findings in breast cancer
4. Kessler Foundation scientists present cognitive research findings at MS dual symposium
5. Researchers present new findings for novel pancreatic cancer vaccine
6. Mayo Clinic urologists present findings at American Urological Association Annual Meeting
7. Once-Banned Bird Flu Study Yields Sobering Findings
8. Columbus Allergist Dr. Summit Shah Discusses Recent Findings on Food Allergies and Exercise-Induced Anaphylaxis
9. Relief for Migraine Sufferers as The Life House Offers New Findings, Free Consults
10. New findings by GW researcher break tanning misconceptions: There is no such thing as a safe tan
11. MRI findings shed light on multiple sclerosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... - Cincinnati, Ohio (PRWEB) , ... December 09, ... ... the production of miniature, folded, pharmaceutical inserts and outserts. As a means ... Device. This addition will enable Flottman to individually code professional inserts (PIs) ...
(Date:12/9/2016)... ... December 09, 2016 , ... An inventor from Cana, Va., wanted to fulfill ... of amusement park rides. , The patent-pending SAFETY STRAP FOR AMPUTEES improves accessibility. It ... could be set up in a matter of minutes, or even seconds. The SAFETY ...
(Date:12/9/2016)... , ... December 09, 2016 , ... "I had a ... inventor from Winchester, Va. "I thought that if the nebulizer had a more child-friendly ... than fearing them." , He developed the patent-pending NEBY to avoid the need to ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... Research Institute (WCRI) officially opened registration today for its 33rd Annual Issues ... Boston, MA . , The theme of the conference is “Persistent Challenges and ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... Management (MTM), adherence, and other pharmacist-delivered patient care services, has announced the promotions ... Eric Hoessel to vice president of sales. , Litsinger joined Mirixa in ...
Breaking Medicine News(10 mins):
(Date:12/9/2016)... , Dec. 9, 2016  RxWiki Inc., a digital ... digital marketing strategies of thousands of pharmacies through its ... Austin Inno,s "50 on Fire" Award in ... "We,re pleased to accept the award as one of ... Chief Executive Officer at RxWiki. "Our platform gives independent ...
(Date:12/8/2016)... , Dec. 8, 2016 IRIDEX Corporation (NASDAQ: ... newly issued shares of common stock, $0.01 par value (the ... underwritten public offering.  The final terms of the Offering will ... pricing, and there can be no assurance as to whether ... expects to use the net proceeds it will receive from ...
(Date:12/8/2016)... , Dec. 8, 2016 Global Interventional ... on the global interventional radiology market analyzes the ... report comprises an elaborate executive summary, including a ... segments and sub-segments. The research is a ... formed the bulk of our research efforts along ...
Breaking Medicine Technology: